X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4560) 4560
Publication (393) 393
Book Review (46) 46
Newsletter (43) 43
Magazine Article (16) 16
Newspaper Article (12) 12
Book Chapter (9) 9
Conference Proceeding (2) 2
Transcript (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Government Document (1) 1
Paper (1) 1
Reference (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3909) 3909
hydroxyurea - therapeutic use (2744) 2744
hydroxyurea (2047) 2047
female (1999) 1999
male (1988) 1988
adult (1496) 1496
index medicus (1347) 1347
middle aged (1345) 1345
hematology (1306) 1306
aged (937) 937
oncology (835) 835
anemia, sickle cell - drug therapy (665) 665
hydroxyurea - administration & dosage (654) 654
adolescent (642) 642
hydroxyurea - adverse effects (616) 616
antineoplastic agents - therapeutic use (582) 582
child (580) 580
animals (558) 558
sickle cell anemia (553) 553
treatment outcome (541) 541
anemia (524) 524
hydroxyurea - pharmacology (484) 484
therapy (480) 480
antisickling agents - therapeutic use (477) 477
antineoplastic combined chemotherapy protocols - therapeutic use (444) 444
sickle cell disease (443) 443
disease (388) 388
children (378) 378
combined modality therapy (334) 334
drug therapy, combination (328) 328
child, preschool (319) 319
pharmacology & pharmacy (317) 317
interferon-alpha - therapeutic use (309) 309
care and treatment (307) 307
anemia, sickle cell - complications (295) 295
medicine, general & internal (293) 293
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (286) 286
anemia, sickle cell - blood (283) 283
essential thrombocythemia (271) 271
follow-up studies (267) 267
polycythemia-vera (265) 265
aged, 80 and over (261) 261
cancer (259) 259
hemoglobin (256) 256
mice (252) 252
chemotherapy (247) 247
young adult (246) 246
time factors (244) 244
pediatrics (242) 242
prognosis (241) 241
thrombocythemia, essential - drug therapy (240) 240
hydroxyurea - analogs & derivatives (234) 234
retrospective studies (234) 234
anemia, sickle cell - therapy (219) 219
article (218) 218
risk factors (218) 218
polycythemia vera - drug therapy (203) 203
chronic myelogenous leukemia (199) 199
research (199) 199
risk-factors (194) 194
analysis (191) 191
drug therapy (191) 191
health aspects (190) 190
clinical trials as topic (183) 183
mutation (181) 181
dose-response relationship, drug (179) 179
medicine & public health (178) 178
blood transfusion (177) 177
leukemia (177) 177
busulfan - therapeutic use (169) 169
leukemia, myelogenous, chronic, bcr-abl positive - therapy (168) 168
risk (162) 162
myeloproliferative disorders (160) 160
hiv infections - drug therapy (159) 159
antineoplastic agents - adverse effects (157) 157
polycythemia vera (155) 155
remission induction (153) 153
drug administration schedule (152) 152
immunology (151) 151
survival (151) 151
prospective studies (149) 149
imatinib mesylate (146) 146
expression (144) 144
patients (143) 143
medicine (141) 141
survival rate (141) 141
anemia, sickle cell - physiopathology (138) 138
hemic and lymphatic diseases (138) 138
survival analysis (138) 138
trial (138) 138
bone marrow transplantation (136) 136
anemia, sickle cell - genetics (135) 135
diagnosis (135) 135
pregnancy (133) 133
radiotherapy (131) 131
anti-hiv agents - therapeutic use (129) 129
antineoplastic combined chemotherapy protocols - adverse effects (129) 129
biochemistry & molecular biology (129) 129
infant (129) 129
management (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4301) 4301
French (103) 103
German (73) 73
Japanese (32) 32
Spanish (32) 32
Polish (29) 29
Russian (22) 22
Italian (16) 16
Chinese (11) 11
Hungarian (8) 8
Dutch (3) 3
Czech (2) 2
Hebrew (2) 2
Portuguese (2) 2
Slovak (2) 2
Danish (1) 1
Finnish (1) 1
Korean (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 14, pp. 1591 - 1597
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2012, Issue 4, p. CD006282
Journal Article
Circulation, ISSN 0009-7322, 05/2012, Volume 125, Issue 17, pp. 2128 - 2137
Background-The French pulmonary hypertension (PH) registry allows the survey of epidemiological trends. Isolated cases of precapillary PH have been reported in... 
Dasatinib | Chronic myeloid leukemia | Vascular complications | Adverse drug events | Pulmonary hypertension | CHRONIC MYELOGENOUS LEUKEMIA | LONG-TERM | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | MYELOPROLIFERATIVE DISORDERS | INHIBITORS IMATINIB | pulmonary hypertension | TYROSINE KINASE | CELL-GROWTH | FAILURE | NILOTINIB | CHRONIC MYELOID-LEUKEMIA | adverse drug events | vascular complications | dasatinib | chronic myeloid leukemia | PERIPHERAL VASCULAR DISEASE | Hypertension, Pulmonary - diagnosis | Follow-Up Studies | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Thiazoles - therapeutic use | Hypertension, Pulmonary - chemically induced | Thiazoles - adverse effects | Antineoplastic Agents - adverse effects | Adult | Female | Registries | Antineoplastic Agents - pharmacology | Hypertension, Pulmonary - drug therapy | Drug Utilization - statistics & numerical data | Endothelin Receptor Antagonists | Bone Morphogenetic Protein Receptors, Type II - genetics | Adverse Drug Reaction Reporting Systems | Treatment Outcome | Piperazines - therapeutic use | Hypertension, Pulmonary - epidemiology | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - adverse effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Pyrimidines - adverse effects | Hydroxyurea - therapeutic use | Aged | Hemodynamics - drug effects | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Benzamides | Care and treatment | Dosage and administration | Drug therapy | Life Sciences | Biochemistry, Molecular Biology
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2009, Volume 124, Issue 6, pp. 1319 - 1325.e3
Background Hypereosinophilic syndrome (HES) is a heterogeneous group of rare disorders defined by persistent blood eosinophilia ≥1.5 × 109 /L, absence of a... 
Allergy and Immunology | hypereosinophilic syndrome | Eosinophil | FIP1L1-PDGFRA | MEPOLIZUMAB | FUSION | IDIOPATHIC EOSINOPHILIA | ALLERGY | LYMPHOCYTIC VARIANT | IMATINIB | PREVALENCE | IMMUNOLOGY | Hypereosinophilic Syndrome - drug therapy | Piperazines - administration & dosage | Eosinophils - metabolism | Oncogene Proteins, Fusion - metabolism | Eosinophils - drug effects | Tryptases - blood | mRNA Cleavage and Polyadenylation Factors - metabolism | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | mRNA Cleavage and Polyadenylation Factors - immunology | Adrenal Cortex Hormones - therapeutic use | Eosinophils - immunology | Oncogene Proteins, Fusion - immunology | Young Adult | Antibodies, Monoclonal, Humanized | Receptor, Platelet-Derived Growth Factor alpha - immunology | Aged, 80 and over | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Child | Hypereosinophilic Syndrome - metabolism | Chemokine CCL17 - blood | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Pyrimidines - administration & dosage | Interferon-alpha - therapeutic use | Hydroxyurea - administration & dosage | Piperazines - therapeutic use | Imatinib Mesylate | Interleukin-5 - blood | Interferon-alpha - administration & dosage | Cyclosporine - therapeutic use | Antibodies, Monoclonal - administration & dosage | Pyrimidines - therapeutic use | Adolescent | Cyclosporine - administration & dosage | Hydroxyurea - therapeutic use | Aged | Benzamides | Hypereosinophilic Syndrome - immunology | Adrenal Cortex Hormones - administration & dosage | Medical personnel | Medical colleges | Allergy | Malpractice | Leukemia | Physicians (General practice) | T cells | Allergic reaction | Growth factors | Flow cytometry | Parasitic diseases | Colleges & universities | Ligands | Drug therapy | Light therapy | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2014, Volume 189, Issue 6, pp. 727 - 740
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 426 - 435
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 24, pp. 2585 - 2591
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2012, Volume 87, Issue 3, pp. 284 - 293
Disease overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms primarily characterized by erythrocytosis and... 
ACUTE-LEUKEMIA | JAK2(V617F) MUTATION | VONWILLEBRAND-FACTOR | PRIMARY PROLIFERATIVE POLYCYTHEMIA | LOW-DOSE ASPIRIN | MYELOPROLIFERATIVE DISORDERS | PROGNOSTIC-FACTORS | PLATELET ACTIVATION |